One-third of CFOs now rank health benefits among their top three operating concerns, and it’s driving cuts to coverage, hiring, and investment.
The US spends far more on prescription medicines than other developed nations and policy efforts are unlikely to narrow the gap.
Amazon should resist trying to disrupt US healthcare and instead focus on delivering a consumer-friendly care experience.
Healthcare membership buyers tend to skew younger, but a new GoodRx offering could tap a broader market of consumers losing coverage while still needing routine care.
Ad watchdog sides with pharma over misleading GLP-1 microdose telehealth marketing—but this scrutiny won't impact sales thanks to high consumer demand.
Oura's smart ring adds blood pressure signals, health records, and clinician chat—further blurring the line between wellness tools and healthcare tools.
It’s slowing adoption of health tools that could help those 65+ more effectively manage their health.
AI is becoming a common stop for second opinions after appointments, and the tech is influencing treatment decisions and follow-ups.
Pharma marketers are struggling to reach healthcare professionals through mass outreach, fueling demand for AI-powered personalization and specialty messaging in trusted HCP channels.
New deals add infectious disease research to its acquisition streak despite the government's mixed messages on vaccine policy.
Consumers want smarter digital health tools: This will push providers, insurers, and tech players to align with consumer demand for greater personalization, intuitiveness, and accurate health insights.
Teens lead in TikTok usage, per our estimates, but a new gov't advisory broadens scrutiny beyond social media, increasing pressure on tech safeguards and pediatric care.
Its roughly 30% average weight loss could expand options and accelerate a tiered treatment market ranging from oral pill convenience to surgical intervention for those with severe obesity.
They still see most health ads on linear TV and favor trusted medical sources. And while they avoid AI and social media for most health purposes, CTV is rising as a trusted digital channel.
Nourish's fresh capital fuels its model that combines GLP-1 drugs with health coaching—an emerging trend as insurers and employers demand proof that digital care reduces wasteful spending.
TrumpRx’s addition of 600 generics to its comparison platform could reshape how patients shop for medicines by increasing transparency and pushing pharmacies to compete more aggressively on cost.
“Wellness buyers” skew wealthy: Targeting affluent consumers may boost short-term margins, but it can limit scale and weaken long-term loyalty.
OTC brands drew far more video and ad views than Rx brands in April, capturing attention where health searches often begin.
Justices reject six pharma companies Medicare drug negotiation appeals, cementing federal discounts for consumers and tightening margins for pharma companies.
Most consumers still respond to healthcare ads despite skepticism, but brands can earn bigger wins with authentic storytelling and trusted medical voices.